Trillium Therapeutics Inc.

(TR:APH)

By |

Profile

Trillium Therapeutics Inc is an immuno-oncology company developing therapies for the treatment of cancer. Its SIRPaFc and CD200 monoclonal antibody targets immuno regulatory pathways that tumor cells exploit to evade the host immune system.

Contact Information

Website: www.trilliumtherapeutics.com
Main Phone: +1 416 595-0627
Address: 2488 Dunwin Drive
State: ON
City / Town: Mississauga
Country: CAN
Postal Code: L5L 1J9

Issuer Information

Exchange: TSX
Employees: 28
NAICS: Pharmaceutical P
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange TSX
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 7.5 7.5 7.5 7.5
Low Target Price Estimate 7.5 7.5 7.5 7.5
Mean Target Price Estimate 7.5 7.5 7.5 7.5
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 11/01/12 11/01/12 11/01/12 11/01/12
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1